Wexford Capital LP Viatris Inc Transaction History

Wexford Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.32 - $12.13 $626,424 - $736,291	-60,700 Reduced 62.77%	36,000 $417,000
Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $450,843 - $539,217	44,860 Added 86.54%	96,700 $1.03 Million
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $584,236 - $701,395	51,840 New	51,840 $618,000

1,142

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.